MSB Quarterly Activities/Appendix 4C Cash Flow Report 30/04/24 PRICE SENSITIVE download Created with Sketch. 416.56KB Share MSB FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA 26/03/24 PRICE SENSITIVE download Created with Sketch. 159.39KB Share MSB Pause in Trading 26/03/24 PRICE SENSITIVE download Created with Sketch. 114KB Share MSB Mesoblast Completes Placement and Entitlement Offer 14/03/24 PRICE SENSITIVE download Created with Sketch. 159.66KB Share MSB FDA Supports Accelerated Approval Pathway for Heart Failure 11/03/24 PRICE SENSITIVE download Created with Sketch. 183.32KB Share MSB MSB Q2 Financial Results and Operational Highlights 29/02/24 PRICE SENSITIVE download Created with Sketch. 486.32KB Share MSB Half Year Financial Results Presentation 29/02/24 PRICE SENSITIVE download Created with Sketch. 1.7MB Share MSB Half Year Report and Accounts (including Appendix 4D) 29/02/24 PRICE SENSITIVE download Created with Sketch. 1.66MB Share MSB FDA Grants Orphan Drug Designation for Revascor 15/02/24 PRICE SENSITIVE download Created with Sketch. 176.6KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 31/01/24 PRICE SENSITIVE download Created with Sketch. 423.11KB Share MSB FDA Grants Rare Pediatric Disease Designation for Revascor 19/01/24 PRICE SENSITIVE download Created with Sketch. 181.5KB Share MSB Information For Retail Shareholders 08/12/23 PRICE SENSITIVE download Created with Sketch. 2.54MB Share MSB Mesoblast Completes Institutional Allocation 05/12/23 PRICE SENSITIVE download Created with Sketch. 197.91KB Share MSB Entitlement Offer and Placement Investor Presentation 04/12/23 PRICE SENSITIVE download Created with Sketch. 2.06MB Share MSB MSB Launches Entitlement Offer and Placement 04/12/23 PRICE SENSITIVE download Created with Sketch. 292.56KB Share MSB Trading Halt 01/12/23 PRICE SENSITIVE download Created with Sketch. 217.16KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 31/10/23 PRICE SENSITIVE download Created with Sketch. 398.85KB Share MSB MSB Annual Financial Results and Operational Update 31/08/23 PRICE SENSITIVE download Created with Sketch. 430.53KB Share MSB Preliminary Final Report including Appendix 4E 31/08/23 PRICE SENSITIVE download Created with Sketch. 2.9MB Share MSB Update on BLA for Graft Versus Host Disease 04/08/23 PRICE SENSITIVE download Created with Sketch. 178.56KB Share MSB Trading Halt 02/08/23 PRICE SENSITIVE download Created with Sketch. 195.14KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 31/07/23 PRICE SENSITIVE download Created with Sketch. 401.67KB Share MSB MSB Reports Q3 Financial Results and Operational Highlights 26/05/23 PRICE SENSITIVE download Created with Sketch. 402.9KB Share MSB Third Quarter Financial Results on Form 6-K 26/05/23 PRICE SENSITIVE download Created with Sketch. 591.58KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 416.6KB Share MSB Reinstatement to Official Quotation 26/04/23 PRICE SENSITIVE download Created with Sketch. 86.01KB Share MSB Mesoblast Completes Private Placement 26/04/23 PRICE SENSITIVE download Created with Sketch. 169.21KB Share MSB Voluntary Suspension 24/04/23 PRICE SENSITIVE download Created with Sketch. 281.47KB Share MSB Trading Halt 20/04/23 PRICE SENSITIVE download Created with Sketch. 281.84KB Share MSB Pause in Trading 20/04/23 PRICE SENSITIVE download Created with Sketch. 115.82KB Share MSB FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L 08/03/23 PRICE SENSITIVE download Created with Sketch. 195.02KB Share MSB Pause in Trading 08/03/23 PRICE SENSITIVE download Created with Sketch. 114.29KB Share MSB DREAM HF Trial Published in JACC 28/02/23 PRICE SENSITIVE download Created with Sketch. 226.95KB Share MSB MSB Q2 Financial Results and Operational Highlights 28/02/23 PRICE SENSITIVE download Created with Sketch. 408.95KB Share MSB Half Yearly Report and Accounts 28/02/23 PRICE SENSITIVE download Created with Sketch. 1.67MB Share MSB Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD 01/02/23 PRICE SENSITIVE download Created with Sketch. 195.59KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 31/01/23 PRICE SENSITIVE download Created with Sketch. 419.11KB Share MSB Extension of Undrawn US$30 million Facility 23/12/22 PRICE SENSITIVE download Created with Sketch. 161.36KB Share MSB Long-Term Survival for Acute GvHD Treatment with Remestemcel 23/11/22 PRICE SENSITIVE download Created with Sketch. 189.85KB Share MSB MSB Q1 Financial Results and Operational Highlights 23/11/22 PRICE SENSITIVE download Created with Sketch. 439.61KB Share MSB First Quarter Financial Results on Form 6-K 23/11/22 PRICE SENSITIVE download Created with Sketch. 500.21KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 31/10/22 PRICE SENSITIVE download Created with Sketch. 419.32KB Share MSB Submits New Information to FDA IND File for SR-aGVHD 03/10/22 PRICE SENSITIVE download Created with Sketch. 168.87KB Share MSB MSB Annual Financial Results and Operational Highlights 31/08/22 PRICE SENSITIVE download Created with Sketch. 386.1KB Share MSB Preliminary Final Report 31/08/22 PRICE SENSITIVE download Created with Sketch. 3.16MB Share MSB US$45 Million Private Placement to Major Shareholders 09/08/22 PRICE SENSITIVE download Created with Sketch. 157.61KB Share MSB Reinstatement to Quotation 09/08/22 PRICE SENSITIVE download Created with Sketch. 85.62KB Share MSB Voluntary Suspension 08/08/22 PRICE SENSITIVE download Created with Sketch. 221.75KB Share MSB Trading Halt 04/08/22 PRICE SENSITIVE download Created with Sketch. 206.88KB Share MSB Pause in Trading 04/08/22 PRICE SENSITIVE download Created with Sketch. 116.13KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 444.42KB Share MSB Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE 19/07/22 PRICE SENSITIVE download Created with Sketch. 185.89KB Share MSB Third Quarter Results Presentation 01/06/22 PRICE SENSITIVE download Created with Sketch. 2.69MB Share MSB MSB Q3 Financial Results and Operational Highlights 01/06/22 PRICE SENSITIVE download Created with Sketch. 402.97KB Share MSB Third Quarter Financial Results on Form 6-K 01/06/22 PRICE SENSITIVE download Created with Sketch. 577.99KB Share MSB Quarterly Activities/Appendix 4C Cash Flow Report 29/04/22 PRICE SENSITIVE download Created with Sketch. 443.8KB Share MSB S&P DJI Announces March 2022 Quarterly Rebalance 04/03/22 PRICE SENSITIVE download Created with Sketch. 175.5KB Share MSB MSB Q2 Financial Results and Operational Highlights 25/02/22 PRICE SENSITIVE download Created with Sketch. 654.15KB Share MSB Second Quarter Results Presentation 25/02/22 PRICE SENSITIVE download Created with Sketch. 2.82MB Share MSB Half Yearly Report and Accounts 25/02/22 PRICE SENSITIVE download Created with Sketch. 948.77KB Share MSB Ulcerative Colitis & Crohns Results Presented at ECCO 21/02/22 PRICE SENSITIVE download Created with Sketch. 192.81KB Share MSB Appendix 4C Quarterly Activity Report 31/01/22 PRICE SENSITIVE download Created with Sketch. 340.86KB Share MSB FDAs OTAT Agrees to Primary Endpoint for Back Pain 16/12/21 PRICE SENSITIVE download Created with Sketch. 171.73KB Share MSB Update on Novartis Agreement 14/12/21 PRICE SENSITIVE download Created with Sketch. 129.26KB Share MSB Pause in Trading 14/12/21 PRICE SENSITIVE download Created with Sketch. 116.22KB Share MSB MSB Q1 Financial Results and Operational Highlights 24/11/21 PRICE SENSITIVE download Created with Sketch. 563.41KB Share MSB First Quarter Financial Results on Form 6-K 24/11/21 PRICE SENSITIVE download Created with Sketch. 518.14KB Share MSB MSB and Oaktree Conclude Refinancing of Senior Debt Facility 22/11/21 PRICE SENSITIVE download Created with Sketch. 133.88KB Share MSB AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes 15/11/21 PRICE SENSITIVE download Created with Sketch. 205.61KB Share MSB Appendix 4C Quarterly Activity Report 29/10/21 PRICE SENSITIVE download Created with Sketch. 345.66KB Share MSB MSB Annual Financial Results and Operational Progress 31/08/21 PRICE SENSITIVE download Created with Sketch. 632.34KB Share MSB Preliminary Final Report including Appendix 4E 31/08/21 PRICE SENSITIVE download Created with Sketch. 2.73MB Share MSB Appendix 4C Quarterly Activity Report 30/07/21 PRICE SENSITIVE download Created with Sketch. 349.24KB Share MSB Mesoblast Update on Chronic Low Back Pain Program 01/07/21 PRICE SENSITIVE download Created with Sketch. 181.33KB Share MSB MSB Reports Q3 Financial Results and Operational Highlight 03/06/21 PRICE SENSITIVE download Created with Sketch. 479.65KB Share MSB Third Quarter Financial Results on Form 6-K 03/06/21 PRICE SENSITIVE download Created with Sketch. 633.63KB Share MSB COVID ARDS Trial Topline 60-Day Results 30/04/21 PRICE SENSITIVE download Created with Sketch. 191.36KB Share MSB Appendix 4C Quarterly Activity Report 30/04/21 PRICE SENSITIVE download Created with Sketch. 368.8KB Share MSB Mesoblast Raises US$110M Led By US Strategic Investor Group 02/03/21 PRICE SENSITIVE download Created with Sketch. 195.87KB Share MSB Half Year Report and Accounts (including Appendix 4D) 26/02/21 PRICE SENSITIVE download Created with Sketch. 806.09KB Share MSB Trading Halt 26/02/21 PRICE SENSITIVE download Created with Sketch. 206.93KB Share MSB Mesoblast Phase 3 Chronic Low Back Pain Results 11/02/21 PRICE SENSITIVE download Created with Sketch. 360.41KB Share MSB Appendix 4C Quarterly Activity Report 29/01/21 PRICE SENSITIVE download Created with Sketch. 209.47KB Share MSB Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF 11/01/21 PRICE SENSITIVE download Created with Sketch. 126.77KB Share MSB Mesoblast Update on COVID-19 ARDS Trial 18/12/20 PRICE SENSITIVE download Created with Sketch. 106.84KB Share MSB Trading halt 16/12/20 PRICE SENSITIVE download Created with Sketch. 155.18KB Share MSB Pause in Trading 16/12/20 PRICE SENSITIVE download Created with Sketch. 116.28KB Share MSB Mesoblast Phase 3 Chronic Heart Failure Results 15/12/20 PRICE SENSITIVE download Created with Sketch. 130.08KB Share MSB Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS 02/12/20 PRICE SENSITIVE download Created with Sketch. 116.21KB Share MSB Novartis and Mesoblast Remestemcel-L Collaboration 20/11/20 PRICE SENSITIVE download Created with Sketch. 147.21KB Share MSB First Quarter Results Presentation 20/11/20 PRICE SENSITIVE download Created with Sketch. 2.18MB Share MSB MSB Q1 Financial Results and Operational Highlights 20/11/20 PRICE SENSITIVE download Created with Sketch. 271.6KB Share MSB First Quarter Financial Results on Form 6-K 20/11/20 PRICE SENSITIVE download Created with Sketch. 590.73KB Share MSB DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial 11/11/20 PRICE SENSITIVE download Created with Sketch. 117.63KB Share MSB COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C 29/10/20 PRICE SENSITIVE download Created with Sketch. 192.37KB Share MSB Update on BLA for Graft Versus Host Disease 02/10/20 PRICE SENSITIVE download Created with Sketch. 93.31KB Share MSB Trading Halt 01/10/20 PRICE SENSITIVE download Created with Sketch. 153.58KB Share MSB MSB Wins Fierce Biotech Innovation Award for Remestemcel-L 15/09/20 PRICE SENSITIVE download Created with Sketch. 109.05KB Share MSB DSMB Recommends Continuation of Phase 3 COVID-19 Trial 04/09/20 PRICE SENSITIVE download Created with Sketch. 110.61KB Share MSB MSB Annual Financial Results and Operational Progress 27/08/20 PRICE SENSITIVE download Created with Sketch. 270.6KB Share
(20min delay)
